Patents by Inventor Marc Derive

Marc Derive has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and kits for predicting the risk of having a cardiovascular disease or event
    Patent number: 10948498
    Abstract: A cardiovascular event or disease is prevented or treated in a subject by measuring the expression level of soluble Triggering Receptors Expressed on Myeloid cells-1 (sTREM-1) level in a sample from the subject and comparing it to a reference level. Based on this comparison, subjects that are at risk of having or developing a cardiovascular event or disease are identified, and administered a suitable therapy.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: March 16, 2021
    Assignees: INOTREM, APHP (Assistance Publique-Hôpitaux de Paris), INSERM (Institut National de la Santé et de la Recherche Médicale), Université de Lorraine
    Inventors: Marc Derive, Sebastien Gibot, Hafid Ait-Oufella, Amir Boufenzer, Tabasomme Simon, Nicolas Danchin
  • Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof
    Patent number: 9815883
    Abstract: The present invention relates to polypeptides fragments derived from the protein TLT-1 and their uses for the treatment of inflammatory conditions and more particularly for the treatment of sepsis.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: November 14, 2017
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), UNIVERSITE DE LORRAINE
    Inventors: Sebastien Gibot, Marc Derive
  • Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases
    Patent number: 9657081
    Abstract: The present invention relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 2 and a function-conservative variant. The invention also relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 1 or SEQ ID NO: 2 and a function-conservative variant for use in the treatment of a cardiovascular disease.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: May 23, 2017
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE LORRAINE
    Inventors: Sebastien Gibot, Amir Boufenzer, Hafid Ait-Oufella, Marc Derive
  • Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof
    Patent number: 9255136
    Abstract: Polypeptide The present invention relates to polypeptides fragments derived from the protein TLT-1 have been isolated and are useful in pharmaceutical preparations used for the treatment of inflammatory conditions such as sepsis.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: February 9, 2016
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Lorraine
    Inventors: Sebastien Gibot, Marc Derive
  • INHIBITING PEPTIDES DERIVED FROM TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1 (TREM-1) TREM-LIKE TRANSCRIPT 1 (TLT-1) AND USES THEREOF
    Publication number: 20150232531
    Abstract: The present invention relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 2 and a function-conservative variant. The invention also relates to a peptide comprising at least 6 consecutive amino acid selected from the amino acid sequence SEQ ID NO: 1 or SEQ ID NO: 2 and a function-conservative variant for use in the treatment of a cardiovascular disease.
    Type: Application
    Filed: September 9, 2013
    Publication date: August 20, 2015
    Inventors: Sebastien Gibot, Amir Boufenzer, Hafid Ait-Oufella, Marc Derive
  • INHIBITING PEPTIDES DERIVED FROM TREM-LIKE TRANSCRIPT 1 (TLT-1) AND USES THEREOF
    Publication number: 20130029921
    Abstract: The present invention relates to polypeptides fragments derived from the protein TLT-1 and their uses for the treatment of inflammatory conditions and more particularly for the treatment of sepsis.
    Type: Application
    Filed: April 8, 2011
    Publication date: January 31, 2013
    Inventors: Sebastien Gibot, Marc Derive